Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of palbociclib in metastatic pancreatic neuroendocrine tumors
2014-003924-34Phase 2Active
- Sponsor
- Spanish Group of Neuroendocrine Tumors
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of palbociclib in islet cell tumor, sponsored by Spanish Group of Neuroendocrine Tumors. Primary endpoint: Objective Response Rate. Started Dec 2014; status: active.
02
Drugs
palbociclib
03
Conditions
islet cell tumor
Beyond the preview
Go deeper on 2014-003924-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003924-34.